SCHEMBL25063149

SCHEMBL25063149

COc1ccc(C(=O)Nc2ncc([N+](=O)[O-])s2)c(C)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 9/20 0.64
RAB9A P51151 9/20 0.61
NPC1 O15118 8/20 0.61
MEN1 O00255 7/20 0.61
KMT2A Q03164 7/20 0.61
PKM P14618 5/20 0.61
ATG4B Q9Y4P1 2/20 0.58
RPS6KB1 P23443 1/20 0.58
CDK2 P24941 1/20 0.58
GSK3A P49840 1/20 0.58
GSK3B P49841 1/20 0.58
CDK5 Q00535 1/20 0.58
AURKB Q96GD4 1/20 0.58
MAPT P10636 5/20 0.56
ALDH1A1 P00352 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
NPSR1 Q6W5P4 2/20 0.56
LMNA P02545 2/20 0.56
MLNR O43193 1/20 0.56
NR1I2 O75469 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29056955 0.88 STAT3 (0.61) STAT3RAB9ANPC1MEN1KMT2A
SCHEMBL25063001 0.86 STAT3 (0.80) STAT3RAB9ANPC1MEN1KMT2A
SCHEMBL25063027 0.85 STAT3 (0.68) STAT3RAB9ANPC1MEN1KMT2A
SCHEMBL28573043 0.85 MEN1 (0.75) STAT3RAB9ANPC1MEN1KMT2A
SCHEMBL25063337 0.84 STAT3 (0.70) STAT3RAB9ANPC1MEN1KMT2A
SCHEMBL29057190 0.84 STAT3 (0.67) STAT3RAB9ANPC1MEN1KMT2A
SCHEMBL25063115 0.84 STAT3 (0.67) STAT3RAB9ANPC1MEN1KMT2A
SCHEMBL25063336 0.84 STAT3 (0.67) STAT3RAB9ANPC1MEN1KMT2A
SCHEMBL25063350 0.83 STAT3 (0.65) STAT3RAB9ANPC1MEN1KMT2A
SCHEMBL25063047 0.82 STAT3 (0.64) STAT3RAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 US disclosed
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 US disclosed
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 US disclosed
CN-116472292-A Modified proteins and protein degrading agents 上海睿跃生物科技有限公司 2023-07-21 CN disclosed
EP-4157888-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS Cullgen (Shanghai), Inc. (CN) 2023-04-05 EP disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 STAT3 3224/4885RAB9A 3280/4885NPC1 3949/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 STAT3 3224/4885RAB9A 3280/4885NPC1 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.